Monday, October 26, 2026 · Daily editionET --:--:--

Stopped early

Phase II Investigation of Prostate Artery Embolization (PAE) Before Radical Prostatectomy in Prostate Cancer Patients

NCT02173522 · Shivank Bhatia · Updated 25 June 2019

What is being tested
Prostate artery embolization (PAE)
For
Prostate Cancer
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 45 years to 79 years. About 4 people. The full rules are on the registry page.
Where
United States
When
Starts or started July 2014, ends 16 June 2017. Registered 25 June 2014.
Results
Posted on the registry on 25 June 2019.

In the researchers' words

The purpose of this study is to determine whether pre-operative prostate artery embolization (PAE) reduces intra-operative blood loss and improves surgical outcomes among prostate cancer patients undergoing robot-assisted laparoscopic radical prostatectomy (RALRP).
ClinicalTrials.gov, NCT02173522

Sites

  • Sylvester Comprehensive Cancer CenterMiami, Florida, United States